Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

The Future of the Oligonucleotide and Peptide Therapeutics Industry

Share this article

In this second edition of the TIDES: Oligonucleotide and Peptide Therapeutics eBook Series, we explore the possible changes in the industry over the next decade. Where are the next goals for oligonucleotide and peptide-based drugs, and what events could be in store for the industry over the next few years?

Join us as we look in depth at survey responses from oligonucleotide and peptide therapeutics professionals around the world on areas such as medical breakthroughs, technology, regulations and diversity in the workplace. We also discuss the progress of macromolecular drugs with industry leaders and ask for their predictions on how the sector will have changed by the year 2030.

The ebook includes:

Click the image below to begin exploring the ebook.
The Future of the Oligonucleotide and Peptide Therapeutics Industry

Share this article